1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Middle East NIPT Market Outlook

Middle East NIPT Market Outlook

  • November 2014
  • -
  • RNCOS
  • -
  • 35 pages

It’s no longer unusual for women to marry post age 30 or to have their first child at 35 years of age. With the rise in the age of mother, her risk of having a baby suffering from Down’s syndrome increases. This is where NIPT, non-invasive procedures to identify subgroups of mothers who may have a baby with birth defects, come into the picture.

Nowadays, women and men are taking longer to complete their education, establish themselves at work, achieve financial independence and get married. As a result, over the past few years, birth rates among women in their teens or early 20s have been declining, while they’ve been rising among women in their early 40s. Apart from these common factors, issues such as consanguinity and advanced maternal age due to large family size are quite prevalent, especially in the Middle East Countries.

According to our report “Middle East NIPT Market Outlook”, the aforementioned factors have led to the emergence of the Middle East as a lucrative market for NIPT, whose total potential for the year 2013 was US$ 1.09 Billion. The report helps shed light on the present scenario in the Middle Eastern countries and elaborates on the role of evolving perception across the region in improving the scope of NIPT.

We have identified key countries within the Middle East which hold the maximum potential for NIPT. These countries include the UAE, Saudi Arabia, Israel, Kuwait and Qatar. In the report, we discuss the various drivers, challenges and regulatory developments that have helped shape the current market. We talk about the contribution of advanced maternal age and consanguinity to the high incidence of Down’s syndrome and its impact on the potential market. For every country, a detailed analysis has been presented in terms of the total number of births, the contribution of high risk mothers within the number of births and the total potential market.

At the end, we have presented recent developments around genetic screening and pregnancy termination that have taken place in the Middle East and their possible impact on the market. The report comes to a conclusion with a future outlook section which emphasizes how with regulatory developments such as Israel’s announcement of making abortions free, the attitudes towards prenatal screening are changing and how it will in turn benefit the NIPT industry.

Table Of Contents

Middle East NIPT Market Outlook
1. NIPT - An Introduction
2. Association of Down's Syndrome Risk to Fetus with Mother's Age
3. Tests Available in the Middle Eastern Market
4. Market Drivers
4.1 Advanced Maternal Age
4.2 Consanguinity
4.3 High Incidence of Down's Syndrome
4.4 Changing Perceptions
4.5 Affluence
5. Challenges
5.1 Unacceptability of Termination of Pregnancy
5.2 Unawareness of Chromosomal Anomalies and Prenatal Tests
6. Regulatory Scenario
6.1 Saudi Arabia
6.2 Israel
6.3 UAE
6.4 Kuwait
6.5 Qatar
7. Market Potential in Key Middle East Countries
7.1 Saudi Arabia
7.2 Israel
7.3 UAE
7.4 Kuwait
7.5 Qatar
8. Recent Developments
9. Future Outlook

List of Figures:

Figure 1: Percentage of High Risk Births (2013)
Figure 2: Global Prevalence of Consanguinity (2009)
Figure 3: Probability of Incidence of Down's syndrome (2003)
Figure 4: Saudi Arabia - Number of Births (Thousands), 2012-2018
Figure 5: Saudi Arabia - Percentage of Births by Mother's Risk of Down's syndrome (%), 2013
Figure 6: Saudi Arabia - Potential NIPT Market (Million US$), 2013
Figure 7: Israel - Number of Births (Thousands), 2012-2018
Figure 8: Israel - Percentage of Births by Mother's Risk of Down's syndrome (%), 2013
Figure 9: Israel - Potential NIPT Market (Million US$), 2013
Figure 10: UAE - Number of Births (Thousands), 2012-2018
Figure 11: UAE - Percentage of Births by Mother's Risk of Down's syndrome (%), 2013
Figure 12: UAE - Potential NIPT Market (Million US$), 2013
Figure 13: Kuwait - Number of Births (Thousands), 2012-2018
Figure 14: Kuwait - Percentage of Births by Mother's Risk of Down's syndrome (%), 2013
Figure 15: Kuwait - Potential NIPT Market (Million US$), 2013
Figure 16: Qatar - Number of Births (Thousands), 2012-2018
Figure 17: Qatar - Percentage of Births by Mother's Risk of Down's syndrome (%), 2013
Figure 18: Qatar - Potential NIPT Market (Million US$), 2013

List of Tables:

Table 1: Comparison of Features of Key NIPT in the Market
Table 2: Risk of Down's syndrome with Rise in Maternal Age
Table 3: NIPT Tests Available in Key Countries of the Middle East
Table 4: Per Capita National Disposable Income at Current Prices (US$)
Table 5: Grounds for Legal Abortion in some Middle Eastern Countries
Table 6: Saudi Arabia - Percentage Contribution of Number of Births by Age of Mother (2007 and 2013)
Table 7: Israel - Percentage Contribution of Number of Births by Age of Mother (2013)
Table 8: UAE - Percentage Contribution of Number of Births by Age of Mother (2008 and 2013)
Table 9: Kuwait - Percentage Contribution of Number of Births by Age of Mother (2011-2013)
Table 10: Qatar - Percentage Contribution of Number of Births by Age of Mother (2009 and 2013)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
The Chinese Market for DNA Sequencing

The Chinese Market for DNA Sequencing

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about recent advances and trends in the Chinese sequencing industry and market. - Analyze the Chinese sequencing market by workflow, including sample preparation products, ...

Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Polymerase Chain Reaction (PCR) Technologies and Global Markets

Polymerase Chain Reaction (PCR) Technologies and Global Markets

  • $ 6650
  • Industry report
  • August 2016
  • by BCC Research

This BCC Research report explores the current and future PCR product market, which includes instruments, reagents and consumables, and software and services. It also looks at innovations, market drivers ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.